InvestorsHub Logo
Followers 91
Posts 11413
Boards Moderated 0
Alias Born 06/06/2014

Re: None

Tuesday, 05/09/2023 9:27:54 AM

Tuesday, May 09, 2023 9:27:54 AM

Post# of 466493
The company is taking the right steps on AD. The 'big' news today is that they recently got the phase 2b/3's preliminary blood/CSF biomarker data, and that it looks encouraging. While the company's view on data results is not entirely reliable, this is still really good to hear. So our next steps - going to the FDA (and others) for accelerated approval - are sensible, given the positive regulatory climate on biomarkers for AD.

Looking forward to seeing those results.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News